Dr Sara Charmsaz

Dr Sara Charmsaz

Junior Council Member

 

Dr. Sara Charmsaz obtained her BS and MS in Biotechnology with academic excellence from Griffith University, Australia in 2009. She then worked as a Research Assistant in QIMR Berghofer medical research institute and subsequently started her PhD in 2010 investigating the role Eph family of receptor tyrosine kinases in cancer and was granted her PhD in 2014 from University of Queensland, Australia. Her work on these projects has resulted in a number of important publications.

She then moved to Ireland in 2015 and joined the Endocrine Oncology team at Royal College of Surgeons (RCSI) and since then she has worked on a number of projects including understanding and defining the role of stem cells in endocrine resistant breast cancer. She has also been working on new monitoring biomarkers of response to endocrine treatment in breast cancer.

In 2016, she joined an SFI-Pfizer project as a lead scientist and is now involved in the research and development of new therapeutic targets for ER-positive metastatic disease.

Phospho-Akt expression and localisation mediated by VEGF in A549 lung cancer cells

Visualised by high content image analysis.

Courtesy of Dr Martin Barr, Clinical Scientist & Adjunct Assistant Professor, St James’s Hospital & Trinity College Dublin

Metaphase chromosome spread of Jurkat T-lymphoma cells

Courtesy of Rebecca Gorry, PhD Student, Mc Gee Lab, UCD School of Biomolecular & Biomedical Science, Conway Institute, UCD  

Apoptosis assessment of SKMES-1 lung cancer cells

Using a multiparameter apoptosis staining kit, showing cell nuclei (blue), actin (green) and mitochondrial activity (orange).

Courtesy of Dr Martin Barr, Clinical Scientist & Adjunct Assistant Professor, St James’s Hospital & Trinity College Dublin

HeLa Cells

Courtesy of Rebecca Gorry, PhD Student, Mc Gee Lab, UCD School of Biomolecular & Biomedical Science, Conway Institute, UCD

55th Annual Conference 2019

20 — 22 February 2019 at Europa Hotel, Belfast

 

 

Mitotic Chronic Myelogenous Leukaemia K562 Cells

Courtesy of Rebecca Gorry, PhD Student, Mc Gee Lab, UCD School of Biomolecular & Biomedical Science, Conway Institute, UCD

Cell to Cell Tweeting

Via nanoparticles (red) in Triple Negative Breast Cancer (TNBC) 

Courtesy of Sinéad Lindsay, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin (UCD) Ireland.

Confocal microscopy analysis of phospho-Akt expression in H460 lung cancer cells in response to hypoxia (0.5% O2).

Courtesy of Dr Martin Barr, Clinical Scientist & Adjunct Assistant Professor, St James’s Hospital & Trinity College Dublin

IACR Membership

We have a number of membership categories available. Find out which membership suits you.

Virtual IACR Cancer Conference

The virtual IACR Annual Meeting takes place 24th - 26th March 2021.

IACR Public Engagement

Would you like to know more about how we involve patients in research, our fundraising, and lay seminars?

Contact Us

4 + 11 =

Latest News

Education Grant 2020

The Irish Association for Cancer Research supported five Educational Grants in 2020. These were made available to postgraduate PhD researchers who had been affected by the Covid-19
 pandemic. 

FACEBOOK

Irish Association
for Cancer Research  

9A Coolkill, Sandyford
Dublin 18, Ireland
D18 C1W3

info@iacr.ie
+353 (0)295 8859

Irish Association for Cancer Research (IACR) is a registered charity on the Register of Charitable Organisations, Charities Regulator, 3 George's Dock, IFSC, Dublin 1, D01 X5X0, Ireland.

Registered Charity Number (RCN): 20030117.

©Design by LetterEleven